Literature DB >> 27219818

The Predictors study: Development and baseline characteristics of the Predictors 3 cohort.

Yaakov Stern1, Yian Gu2, Stephanie Cosentino2, Martina Azar2, Siobhan Lawless2, Oksana Tatarina2.   

Abstract

INTRODUCTION: The Predictors study was designed to predict the length of time to major disease outcomes in Alzheimer's disease (AD) patients. Here, we describe the development of a new, Predictors 3, cohort.
METHODS: Patients with prevalent or incident AD and individuals at-risk for developing AD were selected from the North Manhattan community and followed annually with instruments comparable to those used in the original two Predictors cohorts.
RESULTS: The original Predictors cohorts were clinic based and racially/ethnically homogenous (94% white, 6% black; 3% Hispanic). In contrast, the 274 elders in this cohort are community-based and ethnically diverse (39% white, 40% black, 21% other; 78% Hispanic). Confirming previous observations, psychotic features were associated with poorer function and mental status and extrapyramidal signs with poorer function. DISCUSSION: This new cohort will allow us to test observations made in our original clinic-based cohorts in patients that may be more representative of the general community.
Copyright © 2016 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADL; Cognitive function; Extrapyramidal signs; MCI; Pharmacoeconomics; Prediction algorithms; Psychotic features

Mesh:

Year:  2016        PMID: 27219818      PMCID: PMC5118195          DOI: 10.1016/j.jalz.2016.04.004

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  68 in total

1.  Comparison of three comorbidity measures for predicting health service use in patients with osteoarthritis.

Authors:  Kelli L Dominick; Tara K Dudley; Cynthia J Coffman; Hayden B Bosworth
Journal:  Arthritis Rheum       Date:  2005-10-15

2.  Longitudinal study of quality of life in people with advanced Alzheimer's disease.

Authors:  S M Albert; D M Jacobs; M Sano; K Marder; K Bell; D Devanand; J Brandt; M Albert; Y Stern
Journal:  Am J Geriatr Psychiatry       Date:  2001       Impact factor: 4.105

3.  Evaluating storage, retention, and retrieval in disordered memory and learning.

Authors:  H Buschke; P A Fuld
Journal:  Neurology       Date:  1974-11       Impact factor: 9.910

4.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

5.  Delusions and hallucinations are associated with worse outcome in Alzheimer disease.

Authors:  Nikolaos Scarmeas; Jason Brandt; Marilyn Albert; Georgios Hadjigeorgiou; Alexandros Papadimitriou; Bruno Dubois; Maria Sarazin; Davangere Devanand; Lawrence Honig; Karen Marder; Karen Bell; Domonick Wegesin; Deborah Blacker; Yaakov Stern
Journal:  Arch Neurol       Date:  2005-10

6.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

7.  The absence of an apolipoprotein epsilon4 allele is associated with a more aggressive form of Alzheimer's disease.

Authors:  Y Stern; J Brandt; M Albert; D M Jacobs; X Liu; K Bell; K Marder; M Sano; S Albert; C Del-Castillo Castenada; F Bylsma; B Tycko; R Mayeux
Journal:  Ann Neurol       Date:  1997-05       Impact factor: 10.422

8.  The effects of patient function and dependence on costs of care in Alzheimer's disease.

Authors:  Carolyn W Zhu; Christopher Leibman; Trent McLaughlin; Nikolaos Scarmeas; Marilyn Albert; Jason Brandt; Deborah Blacker; Mary Sano; Yaakov Stern
Journal:  J Am Geriatr Soc       Date:  2008-07-24       Impact factor: 5.562

9.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

10.  The rate of cognitive decline and risk of reaching clinical milestones in Alzheimer disease.

Authors:  Roee Holtzer; Domonick J Wegesin; Steven M Albert; Karen Marder; Karen Bell; Marilyn Albert; Jason Brandt; Yaakov Stern
Journal:  Arch Neurol       Date:  2003-08
View more
  6 in total

1.  Association Between Early Psychotic Symptoms and Alzheimer's Disease Prognosis in a Community-Based Cohort.

Authors:  Reena T Gottesman; Anton Kociolek; Kayri Fernandez; Stephanie Cosentino; D P Devanand; Yaakov Stern; Yian Gu
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

2.  Validation and demonstration of a new comprehensive model of Alzheimer's disease progression.

Authors:  Yaakov Stern; Eric Stallard; Bruce Kinosian; Carolyn Zhu; Stephanie Cosentino; Zhezhen Jin; Yian Gu
Journal:  Alzheimers Dement       Date:  2021-05-14       Impact factor: 21.566

3.  Letter.

Authors:  Ara S Khachaturian
Journal:  Alzheimers Dement (Amst)       Date:  2017-11-21

4.  Assessing Dependency in a Multiethnic Community Cohort of Individuals With Alzheimer's Disease.

Authors:  Maria Meinerding; Brittany DeFeis; Preeti Sunderaraman; Martina Azar; Siobhan Lawless; Carlos Perez-Vivaldo; Yian Gu; Yaakov Stern; Stephanie Cosentino
Journal:  Innov Aging       Date:  2018-05-11

5.  Modification of everyday activities and its association with self-awareness in cognitively diverse older adults.

Authors:  Danielle Shaked; Preeti Sunderaraman; Jennifer Piscitello; Sarah Cines; Christiane Hale; Davangere Devanand; Jason Karlawish; Stephanie Cosentino
Journal:  PLoS One       Date:  2019-11-07       Impact factor: 3.240

Review 6.  Neuropsychological assessment of mild cognitive impairment in Latinx adults: A scoping review.

Authors:  Emily M Briceño; Roshanak Mehdipanah; Xavier Fonz Gonzales; Kenneth M Langa; Deborah A Levine; Nelda M Garcia; Ruth Longoria; Bruno J Giordani; Steven G Heeringa; Lewis B Morgenstern
Journal:  Neuropsychology       Date:  2020-04-13       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.